Dry powder inhaler (DPI) is an attractive dosage form for local and systemic pulmonary drug
delivery. However, designing DPIs with adequate physicochemical properties is …

Inhalation is the preferred route for the treatment of lung diseases. More recently, also
formulations for systemic treatment have been developed. For efficient development of …

In vitro dissolution and permeability testing aid the simulation of the in vivo behavior of
inhalation drug products. Although the regulatory bodies have specific guidelines for the …

Background Incidence of pulmonary aspergillosis is rising worldwide, owing to an increased
population of immunocompromised patients. Notable potential of the pulmonary route has …

In the current study electrospraying methodology was used for particle engineering of
montelukast and budesonide to prepare a combined inhalable dry powder formulation …

To overcome some of the shortfalls of the types of dissolution testing currently used for
pulmonary products, a new custom-built dissolution apparatus has been developed. For …

Tuberculosis resistant cases have been estimated to grow every year. Besides
Mycobacterium tuberculosis, other mycobacterial species are responsible for an increasing …

We combined high-energy wet media milling and spray drying to engineer dry powders for
inhalation consisting of geometrically large, low-density particles with superior aerodynamic …

In this study, we evaluated the aerodynamic performance, dissolution, and permeation
behavior of micronized fluticasone propionate (FP) and magnesium stearate (MgSt) binary …

Neuroinflammation occurs in the early stages of Alzheimer's disease (AD). Thus, anti-
inflammatory drugs in this asymptomatic initial phase could slow down AD progression …